8-Mop/uva Inhibits Maturation Of Extracorporeal Photochemotherapy (ecp) Generated Dendritic Cells [PDF]
, 2011 Extracorporeal photochemotherapy (ECP), a cellular therapy involving a light activated drug, is FDA approved for the treatment of Cutaneous T-cell lymphoma (CTCL) and used for reversal of Graft-versus-Host Disease (GHVD) and solid organ transplant ...
Baird, Abigail Hart
core +1 more source
A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease [PDF]
, 2008 Chronic graft-versus-host disease (cGVHD) is a major limitation of successful hematopoietic cell transplantation. The safety and efficacy of extracorporeal photopheresis (ECP) for 12 to 24 weeks together with standard therapy was compared with standard ...
Apperley, Jane F. +14 more
core +2 more sources
Терапевтический архив, 2012 Aim. To evaluate the clinical efficiency of extracorporeal photochemotherapy (EPCT) in the treatment of psoriasis (Ps) and Ps associated with psoriatic arthritis (PsA). Subjects and methods.
V A Molochkov +5 more
doaj
Modulation Of Immunity By The Immunologic Zipper: The Role Of Glucocorticoid-Induced Leucine Zipper In Extracoporeal Photochemotherapy [PDF]
, 2014 Extracorporeal photochemotherapy (ECP) is a cellular therapy that is FDA approved for the treatment of a variety of T cell mediated diseases, including cutaneous T cell lymphoma, graft-versus-host disease, and solid organ transplantation rejection.
Feng, Hao
core +1 more source
Supplementary Table 1 from Extracorporeal Photochemotherapy Drives Monocyte-to-Dendritic Cell Maturation to Induce Anticancer Immunity [PDF]
, 2023 Alessandra Ventura +10 more
openalex +2 more sources
Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk‐stratification, and management [PDF]
, 2019 Disease OverviewCutaneous T‐cell lymphomas (CTCL) are a heterogenous group of T‐cell neoplasms involving the skin, the majority of which may be classified as Mycosis fungoides (MF) or Sézary syndrome (SS).DiagnosisThe diagnosis of MF or SS requires the ...
Boumsell L +23 more
core +1 more source
Role of extracorporeal photopheresis in the management of acute and chronic graft versus disease: current status [PDF]
Extracorporeal photopheresis (ECP) is a therapy that combines the collection of mononuclear cells by apheresis, the addition of a photosensitizer (8-methoxisoralen), the illumination of the product with ultraviolet A light, and the immediate infusion of ...
Charry, Paola +8 more
core +1 more source
The Glucocorticoid-Induced Leucine Zipper And Immunomodulation In Extracorporeal Photochemotherapy [PDF]
, 2013 Extracorporeal photochemotherapy (ECP) induces antigen-specific immune tolerance in graft-versus-host disease and solid-organ transplant rejection, and involves the ex vivo exposure of peripheral blood mononuclear cells to 8-methoxypsoralen plus ...
Futterleib, Jeffrey Scott
core +1 more source
The Application Of Extracorporeal Photochemotherapy To Head And Neck Squamous Cell Carcinoma [PDF]
, 2019 Extracorporeal Photochemotherapy (ECP) is an FDA-approved immunotherapy that has been treating cutaneous T cell lymphoma (CTCL) for over three decades. ECP’s antitumoral effect is a consequence of its generation of functional, physiologic, inflammatory ...
Yurter, Alp
core +1 more source
Treatment of chronic graft-versus-host disease: Past, present and future [PDF]
, 2011 Chronic GVHD was recognized as a complication of allogeneic hematopoietic cell transplantation more than 30 years ago, but progress has been slowed by the limited insight into the pathogenesis of the disease and the mechanisms that lead to development of
Akpek +103 more
core +2 more sources